Adam W.
- Country
- Poland
- Department
- Department of Cardiology and Interventional Angiology
Research Overview
- Efficacy Evaluation of Acalabrutinib, Venetoclax, and Rituximab in Treatment-Naïve Mantle Cell Lymphoma: A Phase II Multicenter Open-Label Study
- Phase 3 Randomized Study of Obinutuzumab, Acalabrutinib, and Chlorambucil in Untreated Chronic Lymphocytic Leukemia
- Phase 3 Randomized Study of Pirtobrutinib, Venetoclax, and Rituximab in Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Data & Insights
Has run more than one trial at 106 of 435 partner sites.
Specializations
Hematologic Oncology
Specializes in investigating treatments for B-cell lymphoid malignancies, with particular focus on various subtypes of non-Hodgkin lymphoma and chronic lymphocytic leukemia.
- Diffuse Large B-cell Lymphoma
- Mantle Cell Lymphoma
- Follicular Lymphoma
- Secondary Immunodeficiency
Investigates novel therapeutic approaches including targeted therapies and immunotherapy combinations.
Cardiovascular Medicine
Focuses on therapeutic interventions for acute coronary syndrome and complex cardiovascular conditions requiring dual antithrombotic management.
- Acute Myocardial Infarction
- Atrial Fibrillation
- Percutaneous Coronary Intervention
- Antithrombotic Therapy
Evaluates innovative treatment strategies for patients with concurrent cardiac conditions.
Clinical Pharmacology
Conducts research on novel therapeutic agents and their combinations in both hematologic and cardiovascular conditions.
- Targeted Molecular Therapies
- Immunoglobulin Treatments
- Anticoagulation Management
- Emergency Self-Administration Protocols
Explores therapeutic applications across multiple disease states and treatment modalities.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.